NEVIRAPINE 400 mg/1
NEVIRAPINE · TABLET, EXTENDED RELEASE · Macleods Pharmaceuticals Limited
No Recall History
Plain English
NEVIRAPINE is a tablet, extended release containing nevirapine at 400 mg/1, taken oral. Manufactured by Macleods Pharmaceuticals Limited.
Key Facts
- Brand Name
- NEVIRAPINE
- Generic Name
- NEVIRAPINE
- NDC Code (Product)
33342-238- Manufacturer
- Macleods Pharmaceuticals Limited
- Strength
- 400 mg/1
- Dosage Form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- ANDA206879
- Drug Class
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Marketing Start
- 10/07/2017
Recall History
No Recall HistoryFrequently Asked Questions
What is NEVIRAPINE used for?
NEVIRAPINE contains NEVIRAPINE. It is a tablet, extended release taken oral. Consult your doctor for specific uses.
Is NEVIRAPINE a controlled substance?
NEVIRAPINE is not classified as a controlled substance by the DEA.
What is the generic name for NEVIRAPINE?
The generic name for NEVIRAPINE is NEVIRAPINE. There are 7 other brand versions of NEVIRAPINE.
What is the NDC code for NEVIRAPINE 400 mg/1?
The NDC (National Drug Code) for NEVIRAPINE 400 mg/1 is 33342-238, listed by Macleods Pharmaceuticals Limited.